Amgen – Jim Cramer Looks to Buy Stocks for His Portfolio
Now, we’ve got some stocks that just have to come down before we buy more, though. We’re talking behind the scenes about upgrading, putting different numbers on. You can’t just come in to buy AbbVie (ABBV) – Get Report without a reopening. This is a Botox trade. By the way, AbbVie reported better-than-expected earnings and provided upside in 2021 guidance this morning as its immunological franchise — that’s going to be Humira plus two other drugs — continues to outperform. Great yield, eight times earnings. I don’t know. Why do stocks trade the way they do when they should trade much higher? Well, because there are good opportunities.
Now, you can’t just say, let’s go buy Take Two. (TTWO) – Get Report It’s down even though EA (EA) – Get Report was good. It’s going to be a big year for “Grand Theft Auto.” You know, Red Dead. But take it to heart what I said at the top of the presentation. We will buy [CEO] Strauss Zelnick’s stock higher than our basis if we get a chance. No quandaries.
How the heck can Bristol-Myers (BMY) – Get Report – about to report — stay here after all the magnificent moves and trials and successes that obviated Otezla, which they got a lot of money from Amgen. You know what? I think that Bristol-Myers is probably the easiest stock to own in the whole portfolio. Bristol-Myers. [CEO] Giovanni Caforio. He’s good.
All right, here’s one that’s down three bucks in sympathy with a company called S(BA) Communications. Crown Castle. (CCI) – Get Report We got a great activist, Elliott. We got insider buying. Big spectrum auction. It keeps going down. Why? I struggle. Maybe because it’s moronic. Remember when Viacom (VIAB) – Get Report went down? I thought that Viacom was going down because I did bad work. No. Viacom was going down because there were other people doing bad work.
Waste Management. (WM) – Get Report I’m tired of it. Remember what I said in the last call: Being tired of value and tossing it is a sin. I don’t know. If it got back to 118, 119, that’s a Lautrec. Tough ones.
How do you sell CVS (CVS) – Get Report now at 10 times earnings when it’s just about to get millions of new customers from Covid? Well, not from Covid. From getting rid of Covid. We’re not. If it goes any lower, we’re buyers, obviously. If you’re happy with CVS, you’re a moron. I’m not. But I do like the stock because it’s cheap.